NT_1170x120_1-11-18

Prime Therapeutics

Corporate giants team up on employee health care

Corporate giants team up on employee health care

NEW YORK — Three of the largest U.S. companies — Berkshire Hathaway, Amazon and JPMorgan Chase & Co. — have joined together to take employee health care into their own hands. Berkshire Hathaway, Amazon and JPMorgan Chase said Tuesday that they plan to form an independent health care company to provide their employees accessible, affordable and quality care.

Novo Nordisk set to release Ozempic

Novo Nordisk set to release Ozempic

PLAINSBORO, N.J. — Novo Nordisk this week gained Food and Drug Administration approval for Ozempic (semaglutide injection), a medication for type 2 diabetes. Also this week, Novo Nordisk and pharmacy benefit manager Prime Therapeutics said they signed a value-based contract for Victoza (liraglutide injection), another type 2 diabetes medication. A glucagon-like peptide (GLP-1) receptor agonist,

Troubling Rx trends: Drug lawsuit ads, lax opioid disposal

Troubling Rx trends: Drug lawsuit ads, lax opioid disposal

Some recently released research uncovered a couple of disconcerting trends concerning prescription drugs. Lawsuit ads targeting prescription drugs and medical devices have caused at least 61 serious medical events, including six deaths, according to a report from the U.S. Chamber Institute for Legal Reform (ILR). This marks an increase from previous reports, ILR said. Titled

AllianceRx Walgreens Prime up and running

AllianceRx Walgreens Prime up and running

ORLANDO, Fla. — Merging the specialty pharmacy and mail service capabilities of Walgreens and Prime Therapeutics LLC has created a whole that is greater than the sum of its parts, says Joel Wright, chief executive officer of the newly formed AllianceRx Walgreens Prime. Increased purchasing scale and the addition of Prime’s clinical and lives management

Walgreens gets help with Rx disposal effort

DEERFIELD, Ill. — Four prominent players in the health care sector are coming together to help combat opioid abuse by increasing the availability of Walgreens medication disposal kiosks. The goal is to collect 300 tons of unwanted medications over the next two years through kiosks at about 1,500 Walgreens stores nationwide. Walgreens now has about

Walgreens Rx disposal kiosk program adds partners

Walgreens Rx disposal kiosk program adds partners

DEERFIELD, Ill. — AmerisourceBergen, the Blue Cross Blue Shield Association, Pfizer and Prime Therapeutics are helping Walgreens fight the national opioid epidemic by expanding the availability of safe medication disposal kiosks. The drug chain said Wednesday that the effort will bring the medication disposal units to an additional 900 Walgreens stores near military bases and

AllianceRx Walgreens Prime brand makes debut

AllianceRx Walgreens Prime brand makes debut

ORLANDO, Fla. — Walgreens and Prime Therapeutics LLC have inaugurated AllianceRx Walgreens Prime, the brand for the joint central specialty pharmacy and mail services company they formed earlier this year. The companies said the AllianceRx Walgreens Prime launch included the unveiling of new signage at its headquarters in Orlando, Fla., and at other company-owned facilities

WBA, Prime Therapeutics tab leaders for joint venture

DEERFIELD, Ill. — Walgreens Boots Alliance Inc. (WBA) and Prime Therapeutics LLC have completed the formation of a combined central specialty pharmacy and mail service company, a move that was first announced last August. The leadership team of the new enterprise, AllianceRx Walgreens Prime, has also been ­revealed. Joel Wright, formerly divisional vice president for

BCBS specialty Rx FEP contract to shift from CVS to Prime

BCBS specialty Rx FEP contract to shift from CVS to Prime

NEW YORK — Next year, the specialty pharmacy services contract for the Blue Cross and Blue Shield Federal Employee Program (FEP) is slated to pass from CVS Health to Prime Therapeutics LLC. CVS said its specialty pharmacy contract with BCBS FEP will terminate at the end of 2017. Under separate agreements that run through 2018,

Walgreens, Prime Therapeutics launch company

Walgreens, Prime Therapeutics launch company

DEERFIELD, Ill., and ST. PAUL, Minn. — Walgreens and pharmacy benefit manager Prime Therapeutics LLC have completed their transaction to form a joint pharmacy services company and announced its leadership. Called AllianceRx Walgreens Prime and based in Orlando, Fla., the new company melds the central specialty pharmacy and mail service businesses of Walgreens and Prime

Walgreens eyes more efficient health care

Walgreens eyes more efficient health care

DEERFIELD, Ill. — In a country where health care is rife with wasted time and money, Walgreens is committed to making pharmacy more efficient. One measure of the practice’s current inefficiency, says Alex Gourlay, co-chief operating officer of Walgreens Boots Alliance Inc., is the large number of prescriptions that need additional authorization on the way

Rx battle heats up between CVS, Walgreens

Rx battle heats up between CVS, Walgreens

CVS Health’s scaled-back 2017 guidance, given in its third-quarter report this week, spotlights an intensifying competitive battle with rival Walgreens Boots Alliance. CVS reported that for fiscal 2017 it expects to lose over 40 million retail prescriptions due to marketplace changes, notably narrower retail pharmacy networks excluding CVS Pharmacy drug stores. The announcement sent CVS

WBA tops earnings forecast for 4Q, full year

WBA tops earnings forecast for 4Q, full year

DEERFIELD, Ill. — As talks roll on to gain regulatory clearance for its acquisition of Rite Aid Corp., Walgreens Boots Alliance (WBA) posted adjusted earnings for its fiscal 2016 fourth quarter and full year that beat Wall Street’s estimates. WBA said Thursday that GAAP net earnings attributable to Walgreens Boots Alliance totaled $1.03 billion, or

Prime Therapeutics teams up with WBA

Prime Therapeutics teams up with WBA

DEERFIELD, Ill. — The partnership of Walgreens Boots Alliance Inc. (WBA) and pharmacy benefit manager Prime Therapeutics positions the companies to capture a larger share of the prescription drug market and better compete with such players as CVS Health. St. Paul, Minn.-based Prime, the nation’s fourth-largest PBM with 22 million members, is owned by 14